Skip to main content

Peer Review reports

From: Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial

Original Submission
29 Jun 2023 Submitted Original manuscript
21 Jul 2023 Author responded Author comments - Shahpar Haghighat
Resubmission - Version 2
21 Jul 2023 Submitted Manuscript version 2
2 Sep 2023 Reviewed Reviewer Report
20 Sep 2023 Reviewed Reviewer Report
24 Sep 2023 Reviewed Reviewer Report
16 Oct 2023 Author responded Author comments - Shahpar Haghighat
Resubmission - Version 3
16 Oct 2023 Submitted Manuscript version 3
30 Oct 2023 Reviewed Reviewer Report
2 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
5 Nov 2023 Editorially accepted
10 Nov 2023 Article published 10.1186/s12885-023-11614-7

You can find further information about peer review here.

Back to article page